"I spent four decades of my life thinking about how to treat patients with the Ebola virus. This is the achievement of my life, ”Dr. Jean-Jacques Muembé, who, with his team of researchers, has discovered a new treatment for Ebola that can cure the symptoms in just an hour told the BBC .
Four drugs were recently tested on patients in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people in the last year.
It is revealed that more than 90% of infected people can survive if treated early with the latest experimental drugs,
On Tuesday, two people cured of Ebola with the help of experimental drugs were released from a Goma treatment center in the DRC and reunited with their families.
According to the World Health Organization
(WHO), two other treatments called ZMapp and Remdesivir that were
used during the large-scale Ebola epidemic in Sierra Leone, Liberia and Guinea,
have been dropped from the trials since new experimental drugs were the most
The DRC trial, which began in November, has already been halted, while all Ebola wards have been asked to use both experimental or monoclonal antibody drugs.
"From now on, we will no longer say that Ebola is incurable," says Dr. Muimbe, who is also the director general of the National Institute for Biomedical Research in the Congo, has led the process. "This progress will help save thousands of human lives."
In DRC, where there is a large outbreak of the virus – the second largest challenge for controlling the virus are frequent attacks by rebels and high mobility of the population. Authorities and health agencies are also suspected of hindering efforts to curb the response, experts say.
Mumbai, who recently joined scientists to announce
the test results said treatment news could change the course
"Now we can say that 90 percent can go out of treatment, healed, they will begin to trust him and develop confidence," says the 77-year-old, who is part of the team that discovered Ebola 43 years ago, " The first to provide this information are the patients themselves. "
Dr. Muebebe, who is referred to as a "true hero", has
has been fighting Ebola since it first appeared in the DRC (then Zaire) in 1976.
At 34 years old, Muimbe was the first virologist to ever see Ebola
patient and he helped fight all nine of the outbreak strikes
his country since then.
He is a pioneer in the use of survivors' blood serum – which contains antibodies – in order to save patients. The two experimental treatments that have been successful recently stemmed in part from his initial research, according to The New York Times .
When asked how he felt about this, he replied: "I am
a little sentimental. I had this idea a long time ago and waited patiently
for him. I am very happy and I cannot believe it. ”
According to BBC BBC new drugs called REGN-EB3 and mAb114 act by attacking the Ebola virus with antibodies, neutralizing its effect on human cells.
developed using antibodies collected from Ebola survivors while REGN-EB3
comes from antibodies generated in mice infected with the disease, "
Dr. Anthony Focchi, Director
from NIAID said, "They are the" first drugs that are scientifically
study clearly show a significant reduction in mortality. "
Of the patients who were assigned
the two experimental drugs in the study, 29% of REGN-EB3 and 34% of mAb114
died. In contrast, 49% of ZMapp and 53% of Remdesivir (both previously
treatment) died, according to the NIAID.
The Agency added that
survival rate among patients with low levels of the virus in their blood
reached 94% when receiving REGN-EB3 and 89% with mAb114.
the findings mean that more than 90% of people can survive if treated
early, according to a team of scientists who worked in the process.
The team also hopes that the deadly Ebola virus can soon become a preventable and treatable disease. Why Ebola Is Dangerous
Ebola virus (EVD) disease is a serious, often fatal disease in humans. It is often transmitted from animals to humans, and then from humans to humans through direct contact with contaminated blood, body fluids or organs or indirectly through contact with contaminated areas.
Formerly known as Ebola hemorrhagic fever, the disease is named on the Ebola River in the DRC. It was first discovered in 1976.
According to the WHO, the incubation period of the disease is between two and 21 days. Some of the first symptoms include fatigue fever, muscle pain, headache and sore throat. Other symptoms include vomiting, diarrhea, rash, symptoms of impaired renal and hepatic function, and in some cases internal and external bleeding.
Humans remain contagious as long as their blood contains the virus and may also persist in a variety of fluids, including amniotic fluid and placental fluids in pregnant women and breast milk in breastfeeding women during infection.